Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nemus Bioscience (NMUS)

Nemus Bioscience (NMUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 87,040
  • Shares Outstanding, K 133,908
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,190 K
  • 60-Month Beta -0.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 10/05/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4000 +62.50%
on 03/11/19
0.7440 -12.63%
on 03/21/19
+0.1550 (+31.31%)
since 02/22/19
3-Month
0.3000 +116.67%
on 01/31/19
0.7440 -12.63%
on 03/21/19
+0.2501 (+62.54%)
since 12/21/18
52-Week
0.0500 +1,200.00%
on 10/31/18
0.7440 -12.63%
on 03/21/19
+0.4098 (+170.61%)
since 03/22/18

Most Recent Stories

More News
Nemus Bioscience, Inc. Changes Name to Emerald Bioscience, Inc. and Provides Update of Recent Research Accomplishments

NMUS : 0.6500 (-9.52%)
EMBI : 0.3000 (+3.45%)
Nemus Bioscience Reports Nanoemulsion of NB1111 Superior to First-Line Therapy, Latanoprost, in Lowering Intraocular Pressure in Validated Normotensive Animal Model Testing

Prodrug of THC Outperformed Latanoprost at Multiple Timepoints in Multiple Dosing Study

NMUS : 0.6500 (-9.52%)
Imaging3 Update on Execution of Letter of Intent for Reverse Acquisition by Grapefruit Boulevard Investments, Inc.

Imaging3, Inc. (OTCQB:IGNG, "Imaging3" or the "Company"), a development stage company introducing disruptive technologies in the medical imaging industry, is updating and clarifying last week's announcement...

IGNG : 0.0950 (+11.76%)
NMUS : 0.6500 (-9.52%)
LVCA : 0.0028 (+7.69%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7600 (+0.33%)
TRLFF : 0.2845 (-4.59%)
AITB : 5.16 (-0.77%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.4400 (+2.09%)
ATEA : 5.9600 (+3.11%)
CWBHF : 13.6700 (+3.95%)
CVSI : 3.9300 (-0.72%)
DUOT : 0.8000 (+1.27%)
CRLBF : 10.6480 (-0.10%)
ARREF : 0.5245 (+0.87%)
CLOK : 0.9479 (-0.21%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2700 (-0.37%)
HEOFF : 0.8548 (-8.49%)
MJARF : 1.1580 (+8.45%)
ALEAF : 0.9250 (+25.51%)
OTCM : 31.8600 (-8.58%)
NUPMF : 1.8400 (-0.54%)
GLDLF : 0.6973 (-4.48%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3290 (-0.30%)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2671 (-3.75%)
KSHB : 4.6250 (+4.99%)
CORVF : 1.7000 (+1.19%)
ELLXF : 2.5300 (+1.61%)
RSSS : 2.4000 (+0.42%)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0300 (+3.00%)
NWGI : 0.3200 (+6.35%)
QBIO : 1.5300 (unch)
WIZD : 0.1800 (+12.50%)
MRMD : 2.1200 (-0.93%)
GRWG : 3.2600 (+7.24%)
BRTI : 0.1100 (-24.19%)
GTBP : 0.2500 (-3.81%)
MRIC : 3.1000 (unch)
DYAI : 6.00 (+2.92%)
GTBIF : 11.1400 (+6.85%)
MTAFF : 0.7900 (-2.84%)
EMHTF : 1.7700 (-1.67%)
ITHUF : 3.1620 (-0.31%)
ALYE : 4.0000 (+14.29%)
VTLR : 0.1411 (+14.62%)
ARHH : 1.2000 (-4.76%)
OWCP : 0.0159 (-6.47%)
STLHF : 0.6690 (+1.03%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.3200 (+10.34%)
ACRGF : 16.9715 (-0.28%)
Nemus Bioscience to Present at 31st Annual ROTH Conference

via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that...

NMUS : 0.6500 (-9.52%)
Nemus Bioscience Confirms NB1111 Mechanism of Action and Reports Positive Results from Glaucoma Biomarker Studies in Human Donor Tissues

Prodrug of THC Improves Fluid Outflow Across Trabecular Meshwork and Positively Impacts Disease Markers Associated with Glaucoma-Related Fibrosis and Inflammation

NMUS : 0.6500 (-9.52%)
Nemus Bioscience Signs Agreement with Noramco to Manufacture Proprietary Cannabidiol Analog

Enhanced Bioavailability Could Prove Pivotal in Providing Neuroprotection in Diseases of the Retina

NMUS : 0.6500 (-9.52%)
Nemus Bioscience Signs Agreement with Pharmaceuticals International Inc. to Develop Dosage Formulation for Human Dosing with NB1111 for Glaucoma

via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that...

NMUS : 0.6500 (-9.52%)
Nemus Bioscience to Present at BIO CEO & Investor Conference

via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that...

NMUS : 0.6500 (-9.52%)
Innovative Developments in Biotechnology set to Spur the Market Growth

NEW YORK, January 23, 2019 /PRNewswire/ --

NMUS : 0.6500 (-9.52%)
PMCB : 0.0370 (-5.13%)
ENDV : 0.0149 (-23.20%)
SNET : 0.0103 (+63.49%)
ATBPF : 0.2430 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade NMUS with:

Key Turning Points

2nd Resistance Point 0.7752
1st Resistance Point 0.7126
Last Price 0.6500
1st Support Level 0.5937
2nd Support Level 0.5374

See More

52-Week High 0.7440
Last Price 0.6500
Fibonacci 61.8% 0.4789
Fibonacci 50% 0.3970
Fibonacci 38.2% 0.3151
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar